Traditional insulin pumps, often referred to as durable pumps, offer constant and finer delivery of insulin to maintain precise control of glycemic levels. Traditional pumps feature a reservoir of insulin connected to the patient through plastic tubing and a cannula, referred to as an infusion set. A small computer controls the dosage, and is pre-programmed specifically for the patient. The insulin pump is used to deliver both basal and bolus insulin. Basal insulin is delivered continuously at a rate set by the user specific to the time of day. Bolus insulin is injected prior to eating based on what the patient plans to eat and their current blood glucose level. Infusion sets are typically replaced once every three days, while insulin reservoirs are typically replaced once every two to three days. New technological innovations in the traditional pump market include pumps with built-in continuous glucose monitoring (CGM), low glucose suspension algorithms and touchscreen interfaces.
The total U.S. market for insulin pumps can be segmented by pump type, yielding three segments: traditional insulin pumps, patch insulin pumps and simple insulin pumps. In 2016, the largest segment in the total insulin pump market was the traditional pump segment. Traditional pumps account for such a large portion of the market because they are a much more established market, relative to the patch pump and simple pump markets, which were launched in the U.S. in 2005 and 2012, respectively. It is expected that traditional pumps will maintain their dominance over the forecast period, despite the growing market share of patch pumps and simple pumps. Patch pumps are an attractive therapy option for the proportion of the patient population that values the wireless features and significant cost savings on the initial investment of the device, relative to traditional pumps. Although Insulet Corporation currently holds a monopoly in the U.S. market, Cellnovo and other competitors are expected to launch patch pump products over the forecast period and contribute to increased device uptake among the insulin-dependent diabetic population.
'
TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
PROCEDURE CODES INVESTIGATED 10
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 INTRODUCTION 26
2.1.1 Types of Diabetes 26
2.1.2 Diabetes Complications 28
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 30
2.1.4 Signs and Symptoms 31
2.1.5 Diabetes Monitoring 33
2.1.6 Treatment 35
2.1.7 Drug Delivery Systems 36
INSULIN PUMP MARKET 38
3.1 INTRODUCTION 38
3.1.1 Traditional Insulin Pumps 38
3.1.2 Patch Insulin Pumps 38
3.1.3 Simple Insulin Pumps 39
3.2 MARKET OVERVIEW 40
3.3 MARKET ANALYSIS AND FORECAST 44
3.3.1 Total Traditional Insulin Pump Market 44
3.3.1.1 Traditional Pump Market 48
3.3.1.2 Infusion Set Market 50
3.3.1.3 Pump Reservoir Market 52
3.3.2 Total Patch Insulin Pump Market 54
3.3.2.1 Patch Pump System Market 58
3.3.2.2 Insulin Pod Market 60
3.3.3 Simple Insulin Pump Market 62
3.4 DRIVERS AND LIMITERS 65
3.4.1 Market Drivers 65
3.4.2 Market Limiters 67
3.5 COMPETITIVE MARKET SHARE ANALYSIS 69
ABBREVIATIONS 73
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023 3
Chart 3 1: Insulin Pump Market by Segment, U.S., 2013 – 2023 42
Chart 3 2: Insulin Pump Market Breakdown, U.S., 2016 43
Chart 3 3: Insulin Pump Market Breakdown, U.S.,2023 43
Chart 3 4: Total Traditional Insulin Pump Market by Segment, U.S., 2013 – 2023 46
Chart 3 5: Total Traditional Insulin Pump Market Breakdown, U.S., 2016 47
Chart 3 6: Total Traditional Insulin Pump Market Breakdown, U.S., 2023 47
Chart 3 7: Traditional Pump Market, U.S., 2013 – 2023 49
Chart 3 8: Infusion Set Market, U.S., 2013 – 2023 51
Chart 3 9: Pump Reservoir Market, U.S., 2013 – 2023 53
Chart 3 10: Total Patch Insulin Pump Market by Segment, U.S., 2013 – 2023 56
Chart 3 11: Total Patch Insulin Pump Market Breakdown, U.S., 2016 57
Chart 3 12: Total Patch Insulin Pump Market Breakdown, U.S.,2023 57
Chart 3 13: Patch Pump System Market, U.S., 2013 – 2023 59
Chart 3 14: Insulin Pod Market, U.S., 2013 – 2023 61
Chart 3 15: Simple Insulin Pump Market, U.S., 2013 – 2023 64
Chart 3 16: Leading Competitors, Insulin Pump Market, U.S., 2016 72
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, U.S., 2016 6
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 7
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 8
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 – 2016 9
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 10
Figure 1 8: Procedure Codes Investigated, U.S., 2016 10
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2) 11
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2) 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016 27
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016 31
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016 32
Figure 3 1: Insulin Pump Market by Segment, U.S., 2013 – 2023 (US$M) 41
Figure 3 2: Total Traditional Insulin Pump Market by Segment, U.S., 2013 – 2023 (US$M) 45
Figure 3 3: Traditional Pump Market, U.S., 2013 – 2023 48
Figure 3 4: Infusion Set Market, U.S., 2013 – 2023 50
Figure 3 5: Pump Reservoir Market, U.S., 2013 – 2023 52
Figure 3 6: Total Patch Insulin Pump Market by Segment, U.S., 2013 – 2023 (US$M) 55
Figure 3 7: Patch Pump System Market, U.S., 2013 – 2023 58
Figure 3 8: Insulin Pod Market, U.S., 2013 – 2023 60
Figure 3 9: Simple Insulin Pump Market, U.S., 2013 – 2023 63
Figure 3 10: Drivers and Limiters, Insulin Pump Market, U.S., 2016 68
Figure 3 11: Leading Competitors, Insulin Pump Market, U.S., 2016 71
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
